CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Wright Medical Group NV is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Wright Medical Group NV
Prins Bernhardplein 200
Phone: +31 206754002p:+31 206754002 Amsterdam, 1097 JB  Netherlands Fax: +31 104718888f:+31 104718888

This company was Merged or Acquired on 11/11/2020.
This company ceased filing statements with the SEC on 11/23/2020.
This is a Subsidiary, click here for the Parent Company

Business Summary
Wright Medical Group N.V. is a medical device company. The Company is focused on extremities and biologics products. The Company's segments include U.S. Lower Extremities & Biologics, U.S. Upper Extremities and International Extremities & Biologics. Its product portfolio consists of product categories, such as Upper extremities, which includes joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; Lower extremities, which includes joint implants and bone fixation devices for the foot and ankle; Biologics, which includes products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth, and Sports medicine and other, which includes products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries and other ancillary products.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/27/202012/29/2019YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Independent Chairman of the Board David D.Stevens 68 10/1/2015 10/1/2015
President and Chief Executive Officer, Executive Director Robert J.Palmisano 77 10/1/2015 10/1/2015
Executive Vice President, Chief Financial and Operations Officer Lance E.Berry 49 1/1/2019 10/1/2015
12 additional Officers and Directors records available in full report.

Business Names
Business Name
2Hip Holdings SAS
Alias BioMimetic Therapeutics Limited
Alias BioMimetic Therapeutics Pty Ltd.
57 additional Business Names available in full report.

General Information
Number of Employees: 3,030 (As of 12/29/2019)
Outstanding Shares: 129,934,836 (As of 10/28/2020)
Shareholders: 299
Stock Exchange: NASD
Federal Tax Id: 980509600
Fax Number: +31 104718888


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, March 1, 2024